• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics
22 December 2021

Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics

Haven't read our recent publication on engineered #nanovesicles for #nucleicacids delivery yet?

In the following article we report the first findings and advantages of this novel small #RNA delivery system developed with INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA (ICMAB-CSIC) and Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca:

➡️ Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics

✅ pH-sensitive nanovesicles with outstanding colloidal #stability.

✅ They protect nucleic acids such as #miRNA from possible #degradation and deliver them #intracellularly.

✅ PoC for the treatment of neuroblastoma disease, a pediatric cancer.

✅ Use of our green DELOS #technology for the #formulation of nanovesicles.

✅#Scalable and #GMP-compliant manufacturing process to ensure smooth access to clinical stages.

In conclusion, the pH-sensitive #nanocarriers reported here constitute a new platform for delivering small #RNA in vitro and in vivo and have the potential to be used for the treatment of high-risk #neuroblastoma, and also to treat or prevent other #cancers or human #diseases.

If you are interested in nucleic acid #delivery, do not hesitate to #contact us!

Related
news

NANOMOL TECHNOLOGIES EN PROCÉS DE CONTRACTACIÓ D'UN OFICIAL ADMINISTRATIU! 13 May 2024

NANOMOL TECHNOLOGIES EN PROCÉS DE CONTRACTACIÓ D'UN OFICIAL ADMINISTRATIU!

New nanocarrier for bio-imaging and drug-delivery applications 24 January 2020

New nanocarrier for bio-imaging and drug-delivery applications

PHOENIX-OITB Launches 2nd Round of its Open Call Offering Funded Services in Nanopharmaceutical Development 08 April 2024

PHOENIX-OITB Launches 2nd Round of its Open Call Offering Funded Services in Nanopharmaceutical Development

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2026

Nanomol Technologies S.L.

Site by Suki